Public Health

As a new coronavirus spreads across continents, numerous biomedical researchers have turned their focus to the pandemic and its impacts. Online publishing platforms are helping them share what they’ve learned quickly so medical professionals, government leaders and others can respond more quickly to prevent, treat and control infections.

This article was updated on April 3 to reflect the employment situation summary released that day.

Government officials and public health leaders worldwide have worked around the clock battling the new coronavirus. Meanwhile, another pandemic requires their attention — the anxiety, depression, grief and fear that spread across communities as the death toll rises and schools, businesses and public places close to prevent COVID-19 infections.

Misinformation on social media was bad before the coronavirus pandemic, and it’s only gotten more harmful in the age of social distancing now that lives are on the line and millions of Americans are getting their daily dosage of human interaction and information solely from the virtual world.

As a novel coronavirus spreads in China and to other countries, research remains limited on the global economic consequences of the outbreak. Here’s what we know so far.

For several weeks, journalists and researchers worldwide have worked long hours to provide up-to-date information on the new coronavirus disease, known as COVID-19, trying to help members of the public avoid infection while also scrambling to understand the virus and its possible impacts.

Randomized, controlled clinical trials are studies in which a new intervention, such as a medical device, is randomly assigned to some participants and tested against a control group, which receives a standard treatment or a placebo to determine its effects. They often are considered the gold standard of medical studies because they can provide evidence of causation.